LncRNA ADAMTS9-AS2 is a Prognostic Biomarker and Correlated with Immune Infiltrates in Lung Adenocarcinoma.

Zhichao LinWenhai HuangYongsheng YiDongbing LiZehua XieZumei LiMin Ye

Published in: International journal of general medicine (2021)

In LUAD patients, ADAMTS9-AS2 expression was significantly associated with poor survival and immune infiltration. ADAMTS9-AS2 may be a promising biomarker of prognosis and response to immunotherapy for LUAD.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
poor prognosis
chronic kidney disease
peritoneal dialysis